Elitek Kit
Product Images NDC 0024-5151

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Elitek (NDC 0024-5151). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi-aventis U.s. Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (0ae10bc4 6b65 402f 9db5 2d7753054922 01)

Box plot chart illustrating plasma uric acid levels (mg/dL) over time from the first dose in hours for Elitek (rasburicase) treatment. The x-axis shows time points from baseline up to 96 hours with sample sizes for each time point, and the y-axis shows plasma uric acid concentrations ranging from 0 to 16 mg/dL. Data depicts changes in uric acid levels following dosing.*

FDA Label Image

Figure (0ae10bc4 6b65 402f 9db5 2d7753054922 02)

A box plot graph depicting plasma uric acid levels (mg/dL) over time (hours) from the first dose for three treatment arms: Elitek alone (A), Elitek plus Allopurinol (B), and Allopurinol alone (C). Time points range from baseline to 144 hours, with plasma uric acid concentrations shown for each group including variability indicated by error bars.*

FDA Label Image

Principal Display Panel (1.5 mg Kit Carton)

Packaging label for Elitek 1.5 mg kit containing rasburicase for intravenous infusion. The box indicates reconstitution with accompanying diluent before use and states the kit includes three single-dose vials and three diluent ampules. Labeler is Sanofi-Aventis U.S. LLC. The product is labeled Rx only and sterile with no preservatives.*

FDA Label Image

Principal Display Panel (7.5 mg Kit Carton)

Carton packaging label for Elitek 7.5 mg rasburicase KIT, indicated for intravenous infusion. The label includes instructions to reconstitute with the accompanying diluent before use and notes the product contains one single-dose vial and one diluent ampule. The labeler is Sanofi-Aventis U.S. LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.